Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
Lynce F, Blackburn MJ, Zhuo R, Gallagher C, Hahn OM, Abu-Khalaf M, Mohebtash M, Wu T, Pohlmann PR, Dilawari A, Tiwari SR, Chitalia A, Warren R, Tan M, Shajahan-Haq AN, Isaacs C. Lynce F, et al. Among authors: shajahan haq an. Cancer. 2021 Oct 1;127(19):3622-3630. doi: 10.1002/cncr.33620. Epub 2021 Jun 22. Cancer. 2021. PMID: 34157782 Free article. Clinical Trial.
Systems Approaches to Cancer Biology.
Archer TC, Fertig EJ, Gosline SJ, Hafner M, Hughes SK, Joughin BA, Meyer AS, Piccolo SR, Shajahan-Haq AN. Archer TC, et al. Cancer Res. 2016 Dec 1;76(23):6774-6777. doi: 10.1158/0008-5472.CAN-16-1580. Epub 2016 Nov 18. Cancer Res. 2016. PMID: 27864348 Free PMC article.
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.
Lynce F, Saleh M, Shajahan-Haq A, Gallagher C, Dilawari A, Hahn O, Abu-Khalaf M, Cai L, Pohlmann P, Mohebtash M, Kamugisha L, Isaacs C. Lynce F, et al. Contemp Clin Trials Commun. 2018 May 7;10:190-192. doi: 10.1016/j.conctc.2018.05.012. eCollection 2018 Jun. Contemp Clin Trials Commun. 2018. PMID: 30009277 Free PMC article.
Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.
Salamone JM, Lucas W, Brundage SB, Holloway JN, Stahl SM, Carbine NE, London M, Greenwood N, Goyes R, Chisholm DC, Price E, Carlin R, Winarsky S, Baker KB, Maues J, Shajahan-Haq AN. Salamone JM, et al. Cancer Res. 2018 Oct 15;78(20):5723-5728. doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17. Cancer Res. 2018. PMID: 30120210 Free PMC article. Review.
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.
Lynce F, Barac A, Geng X, Dang C, Yu AF, Smith KL, Gallagher C, Pohlmann PR, Nunes R, Herbolsheimer P, Warren R, Srichai MB, Hofmeyer M, Cunningham A, Timothee P, Asch FM, Shajahan-Haq A, Tan MT, Isaacs C, Swain SM. Lynce F, et al. Breast Cancer Res Treat. 2019 Jun;175(3):595-603. doi: 10.1007/s10549-019-05191-2. Epub 2019 Mar 9. Breast Cancer Res Treat. 2019. PMID: 30852761 Free PMC article. Clinical Trial.
29 results